Skip to main content

Table 3 Disability and functional outcomes of the studies

From: Stroke epidemiology and outcomes of stroke patients in Nepal: a systematic review and meta-analysis

STUDY

Disability/outcomes

Cherian I. et al. 2018 [32]

GOS Moderate disability at 6 weeks = 28/102 (27.5%)

Dhungana K et al. 2019 [49]

At discharge,

mRS 1 = 10/96

mRS 2 = 36/96

mRS 3 = 35/96

mRS 4 = 11/96

mRS 5 = 4/96

Gajurel BP et al. 2014 [50]

Mean MRS score at 1 month = 3.58 ± 1.5

mRS 0 = 1/101

mRS 1 = 5/101

mRS 2 = 18

mRS 3 = 34

mRS 4 = 15

mRS 5 = 9

mRS 6 = 19

Jwarchan B et al. 2020 [35]

Association of comorbidities with good outcome mRS 0–1 and poor outcome mRS 2–6 seen

Karn R et al. 2018 [51]

Mean mRS score at 1 month = 2.66 ± 1.803

Mean mRS score at 6 months = 2.71 ± 2.013

Khattar NK et al. 2019 [36]

At discharge,

GOS 1 = 12/21

GOS 2–4 = 7/21

GOS 5 = 2/21

Poudel RS et al. 2015 [21]

At 3 months,

No symptoms at all (mRS 0) = 4/37

No significant disability (mRS 1) = 9/37

Slight disability (mRS 2) = 7/37

Moderate disability (mRS 3) = 5/37

Moderate severe disability (mRS 4) = 4/37

Death (mRS 6) = 8/37

Shah B et al. 2020 [56]

At 1 month of stroke onset,

Total functional dependence = 5/60

Partial functional dependence = 19/60

Independent = 11/60

Total functional dependence = 25/60

Shrestha S et al. 2015 [57]

At 3 months,

Independent = 29/56

Dependent = 11/56

Death = 16/56

Shrestha R et al. 2018 [43]

At discharge, mRS 4 = 12/12

At 3 months, mRS 2 = 7/12, mRS 3 = 5/12

Thapa L et al. 2016 [44]

At discharge,

mRS 0 = 4/9,

mRS 3 = 2/9,

mRS 4 = 1/9,

mRS 5 = 2/9

Thapa A et al. 2018 [45]

At discharge,

mRS < 2 = 558/946 (58.9%)

At the end of 3 years,

mRS < 2 = 115/130 (88.5%)

Shakya D et al. 2019 [27]

WHODAS mean score = 46.0 ± 23.6

HRQOLISP mean score = 60.6 ± 13.6